Skip to content

Electromyography Assessing Treatment in Pediatrics

Evaluating the use of electromyography for assessing treatment for children with bronchial obstruction and hyperresponsiveness in pediatric care

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON24834
Enrollment
50
Registered
2019-07-11
Start date
2019-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astma, bronchial hyper responsiveness and bronchial obstruction

Interventions

None listed

Sponsors

Medisch Spectrum Twente
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: children with bronchial obstruction and bronchial hyper responsiveness in need of bronchodilator treatment, ages: 4 -16 years

Exclusion criteria

Exclusion criteria: Admittance to ICU, children of parents with insufficient knowledge of the Dutch language, children with a pacemaker/ICD, children born prematurely (<32 weeks of gestation)

Design outcomes

Primary

MeasureTime frame
EMG parameters correlated to standard lung function test determining its use providing information on the efficiency of treatment

Secondary

MeasureTime frame
The difference in EMG and its recovery between children with less and increased respiratory distress

Contacts

Public ContactLoes Zaremba

Medisch Spectrum Twente / Kindergeneeskunde

l.zaremba@mst.nl+31681706999

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)